Malignant pleural mesothelioma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up (Q59274199)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20555061%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

title

Malignant pleural mesothelioma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20555061%20AND%20SRC:MED&resulttype=core&format=json

malignant pleural mesothelioma

5 February 2020

main subject

diagnosis

0 references

1 reference

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20555061%20AND%20SRC:MED&resulttype=core&format=json

ESMO Guidelines Working Group

5 February 2020

5

object named as

ESMO Guidelines Working Group

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20555061%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

author name string

R A Stahel

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20555061%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

W Weder

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20555061%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

Y Lievens

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20555061%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

publication date

1 May 2010

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20555061%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20555061%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

volume

21 Suppl 5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20555061%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

issue

Supplement 5

0 references

page(s)

v126-8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20555061%20AND%20SRC:MED&resulttype=core&format=json

The Mesothelioma epidemic in Western Europe: an update

5 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDQ173

Mesothelin-family proteins and diagnosis of mesothelioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDQ173

Soluble mesothelin-related peptide level elevation in mesothelioma serum and pleural effusions

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDQ173

Statistical validation of the EORTC prognostic model for malignant pleural mesothelioma based on three consecutive phase II trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDQ173

Prognostic factors for malignant mesothelioma in 142 patients: validation of CALGB and EORTC prognostic scoring systems

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDQ173

Multicenter phase II trial of neoadjuvant pemetrexed plus cisplatin followed by extrapleural pneumonectomy and radiation for malignant pleural mesothelioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDQ173

Trimodality therapy with induction chemotherapy followed by extrapleural pneumonectomy and adjuvant high-dose hemithoracic radiation for malignant pleural mesothelioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDQ173

Prophylactic radiotherapy to intervention sites in mesothelioma: a systematic review and survey of UK practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDQ173

Phase III study of pemetrexed in combination with cisplatin versus cisplatin alone in patients with malignant pleural mesothelioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDQ173

Randomized phase III study of cisplatin with or without raltitrexed in patients with malignant pleural mesothelioma: an intergroup study of the European Organisation for Research and Treatment of Cancer Lung Cancer Group and the National Cancer Inst

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDQ173

Phase II study of pemetrexed in combination with carboplatin in patients with malignant pleural mesothelioma (MPM).

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDQ173

Phase III trial of pemetrexed plus best supportive care compared with best supportive care in previously treated patients with advanced malignant pleural mesothelioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDQ173

The efficacy and safety of weekly vinorelbine in relapsed malignant pleural mesothelioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDQ173

21 January 2018

Identifiers

DOI

10.1093/ANNONC/MDQ173

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20555061%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

1 reference